News | ASTRO | May 04, 2020

ASTRO's Annual Meeting Transitions to Digital Format

The ASTRO Board has decided to transition its Annual Meeting, October 25-28, to an online format this year, with more details to follow in the near future

#coronavirus #covid19 #pandemic #ASTRO20

May 4, 2020 — Although the 2020 ASTRO Annual Meeting is still months away, the American Society for Radiation Oncology (ASTRO) Board of Directors has decided to transition its live meeting in Miami to an immersive and interactive virtual meeting that will occur over the same dates, October 25-28.

ASTRO President Thomas J. Eichler, M.D., FASTRO, stated in a written announcement that this decision was based on our overwhelming concern for the safety and well-being of ASTRO's members, their patients, exhibitors, staff and the families of all involved. Eichler stated:

"As president of ASTRO, I've seen first-hand what goes into planning a meeting of this magnitude over the past 18 months. Making this decision now allows us to focus our full efforts on providing a comprehensive and groundbreaking virtual meeting — like none other you have experienced. The 2020 ASTRO Annual Meeting — Global Oncology: Radiation Therapy In A Changing World — will include a complete Annual Meeting experience from the Presidential Symposium, to the Plenary Session and Clinical Trials; from Education and Scientific Sessions, to an interactive Exhibit Hall; innovative networking opportunities and so much more.

"The scientific research presented at the Annual Meeting is an invaluable asset to both academic and community radiation oncology practices around the world. Our unwavering commitment to you is to disseminate this critical cancer research in a unique and engaging way. The Program Planning Committee has already selected more than 120 education, workshop, masterclass and panel sessions, as well as more than 2,500 abstracts that will be delivered in oral or poster sessions."

Eichler stated that the Board will continue to update its members as plans for the meeting unfold. You can view this available information in ASTRO's initial FAQs, which will be updated regularly. 

"Although we will miss the opportunity to see each other face to face in Miami this fall, we look forward to delivering a world-class 2020 Annual Meeting experience," Eichler concluded. "Thank you for all that you do for ASTRO and, most importantly, for those we serve: our patients. You have my deepest appreciation. I look forward to seeing you virtually in Miami! Stay safe, be well."

For more information: www.astro.org

Related Content

ASG well positioned for growth as healthcare marketplace continues to evolve 

Allan Klotsche

News | Radiology Imaging | November 24, 2020
November 24, 2020 — Alpha Source Group (ASG), a comprehensive next-generation services partner, has named...
Videos | Coronavirus (COVID-19) | November 20, 2020
This video shows a computed tomography (CT) scroll through showing bowel ischemia and perforation (see arrows) due to
Chest X-ray image of patient with lung injury due to vaping. Image courtesy of UC Regents #COVID19 #pandemic

Chest X-ray image of patient with lung injury due to vaping. Image courtesy of UC Regents

News | Coronavirus (COVID-19) | November 19, 2020
November 19, 2020 — A UC Davis Health ped
1H-MR spectra of 3 consecutive patients with COVID-19. Upper row: Axial FLAIR images at the corona radiata level show representative MRS voxels (black squares) from sampled periventricular regions. Lower row: Corresponding spectrum (black) and LCModel fit (red) from each patient acquired at TE = 30 ms (upper row) and TE = 288 ms (lower row). A, A patient with COVID-19-associated multifocal necrotizing leukoencephalopathy shows diffuse patchy WM lesions with markedly increased Cho and decreased NAA, as well

1H-MR spectra of 3 consecutive patients with COVID-19. Upper row: Axial FLAIR images at the corona radiata level show representative MRS voxels (black squares) from sampled periventricular regions. Lower row: Corresponding spectrum (black) and LCModel fit (red) from each patient acquired at TE = 30 ms (upper row) and TE = 288 ms (lower row). A, A patient with COVID-19-associated multifocal necrotizing leukoencephalopathy shows diffuse patchy WM lesions with markedly increased Cho and decreased NAA, as well as elevated Lac. B, A patient with COVID-19 after recent PEA cardiac arrest with subtle FLAIR hyperintense white matter changes also shows elevated Cho/Cr and decreased NAA/Cr ratios. However, these derangements are less severe than in the patient in A. There is no clear elevation of Lac. C, A patient with COVID-19 without encephalopathy or recent severe hypoxia has normal Cho/Cr, with mildly decreased NAA/Cr and no lactate elevation. Cho, Choline; NAA, N-Acetyl-Aspartate; mI, Myo-Inositol; Lac, Lactate; Glx, Glutamate + Glutamine. Image courtesy of AJNR

News | Coronavirus (COVID-19) | November 19, 2020
November 19, 2020 — One of the first spectroscopic imaging-based studies of neurological injury in...
During active surveillance, prostate cancer is carefully monitored for signs of progression through regular prostate-specific antigen (PSA) screening, prostate exams, imaging, and repeat biopsies.

Getty Images

News | Prostate Cancer | November 18, 2020
November 18, 2020 — ...